Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding
- 1 October 2004
- journal article
- Published by Elsevier BV in Contraception
- Vol. 70 (4), 281-287
- https://doi.org/10.1016/j.contraception.2004.04.007
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A multicenter, randomized study of an extended cycle oral contraceptiveContraception, 2003
- Oral contraceptives, tubal sterilization, and functional ovarian cyst riskPublished by Ovid Technologies (Wolters Kluwer Health) ,2003
- Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trialObstetrics & Gynecology, 2003
- Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trialContraception, 2003
- Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptomsAmerican Journal of Obstetrics and Gynecology, 2002
- Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial1 , *1Obstetrics & Gynecology, 2001
- Hormone withdrawal symptoms in oral contraceptive usersObstetrics & Gynecology, 2000
- Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activityFertility and Sterility, 1999
- Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptomsObstetrics & Gynecology, 1997
- Shorter pill-free interval in combined oral contraceptives decreases follicular developmentContraception, 1996